calgaryherald.com
Calgary medical research company signs $1B deal to develop new drugs for autoimmune diseases
A local company born out of medical research conducted at the University of Calgary has signed a $1 billion (Cdn) deal to develop and commercialize revolutionary new drugs for autoimmune disease.